Search Tag: Pseudomonas aeruginosa

ICU Management

Long-vs-short-duration-antibiotic-therapy-for-vap

2022 24 May

Ventilator-associated pneumonia (VAP) is a major cause of morbidity and mortality in the ICU. It accounts for nearly 25% of infections in ICU patients. While there are guidelines to treat VAP, uncertainties remain when treating VAP due to Pseudomonas aeruginosa (PA-VAP), and the optimal duration of antibiotic therapy continues to be debated. In addition,...Read more

Executive Health Management

Evaluation-of-the-microbial-tightness-of-mini-spike-r-2-chemo-v-a-closed-system-transfer-device

2019 08 Aug

In vitro study validating the microbial barrier function by means of airborne contamination Jürgen Gebel, Sapuna Kuriakose, Barbara Grüter, Martin Exner; University of Bonn Hospital, Institute for Hygiene and Public Health, Germany   BACKGROUND Nosocomial infections pose a major problem in the healthcare system because they contribute...Read more

Executive Health Management

Evaluation-of-the-microbial-tightness-of-the-safeflow-valve-a-closed-system-transfer-device

2019 08 Aug

In vitro study validating the microbial barrier function by means of airborne and touch contamination Juergen Gebel, Sapuna Kuriakose, Barbara Griiter, Martin Exner; University of Bonn Hospital, Institute for Hygiene and Public Health, Germany BACKGROUND Nosocomial infections pose a major problem in the healthcare system because...Read more

Executive Health Management

Microbial-tightness-of-cyto-set-r-cyto-set-r-mix-two-closed-system-transfer-devices-evaluation

2019 08 Aug

In vitro study validating  the microbial barrier function by means of airborne contamination Juergen Gebel, Sapuna Kuriakose, Barbara Griiter, Martin Exner; University of Bonn Hospital, Institute for Hygiene and Public Health, Germany BACKGROUND Nosocomial infections pose a major problem in the healthcare system because they...Read more

ICU Management

New-treatment-for-antibiotic-resistant-bacteria

2017 03 Apr

A new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and care providers is described in a report in American Journal of Respiratory and Critical Care Medicine. Researchers say the unusual approach of removing antibodies from the blood stream could reduce the effects of chronic infections, the...Read more